Compounds and methods for treating autoimmune disorders by targeting HLA-DQ2
Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of an autoimmune disease by modulating the T cell response to antigenic peptide or fragments of antigenic peptides presented by the major histocompatibility (MHC) class II molecule, DQ2.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
26.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of an autoimmune disease by modulating the T cell response to antigenic peptide or fragments of antigenic peptides presented by the major histocompatibility (MHC) class II molecule, DQ2. |
---|---|
Bibliography: | Application Number: US202117407565 |